Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

Nature Medicine

Volumn 5, Issue 5, 1999, Pages 495-502

  Carmeliet, Peter ^a   Ng, Yin Shan ^b   Nuyens, Dieter ^a   Theilmeier, Gregor ^a   Brusselmans, Koen ^a   Cornelissen, Ivo ^a   Ehler, Elisabeth ^c   Kakkar, Vijay V ^d   Stalmans, Ingeborg ^a   Mattot, Virginie ^a   Perriard, Jean Claude ^c   Dewerchin, Mieke ^a   Flameng, Willem ^e   Nagy, Andras ^f   Lupu, Florea ^d   Moons, Lieve ^a   Collen, Désiré ^a   D'Amore, Patricia A ^b   Shima, David T ^b,g  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c ETH ZURICH   (Switzerland)

^d THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f MOUNT SINAI HOSPITAL   (Canada)

^g IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HEART PERFORMANCE; ISCHEMIC HEART DISEASE; MOUSE; MYOCARDIAL HIBERNATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

EID: 0032925156     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/8379     Document Type: Article

References (45)

1. Ferrara, N. & Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4-25 (1997).
2. Isner, J.M. & Takayuki, A. Therapeutic angiogenesis. front. Biosci. 3, e-49-69 (1998).
3. Klagsbrun, M. & D'Amore, P.A. Vascular endothelial growth factor and its receptors. Cytokine Growth factor Rev. 7, 259-270 (1996).
4. Dvorak, H.F., Brown, L.F., Detmar, M. & Dvorak, A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039 (1995).
5. Neufeld, G., Cohen, T., Gengrinovitch, S. & Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22 (1999).
6. Keyt, B.A. et al. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency, J. Biol. Chem. 271, 7788-7795 (1996).
7. Cheung, N., Wong, M.P., Yuen, S.T., Leung, S.Y. & Chung, L.P. Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon. Hum. Pathol. 29, 910-914 (1998).
8. Soker, S., Takashima, S., Miao, H.Q., Neufeld, G. & Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745 (1998).
9. Takeshita, S. et al. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 75, 487-501 (1996).
10. Cheng, S.Y., Nagane, M., Huang, H.S. & Cavenee, W.K. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc. Natl. Acad. Sci. USA 94, 12081-12087 (1997).
11. Tokunaga, T. et al. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br. J. Cancer 77, 998-1002 (1998).
12. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single vascular endothelial growth factor allele. Nature 380, 435-439 (1996).
13. Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442 (1996).
14. Shima, D.T. et al. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271, 3877-3883 (1996).
15. Flameng, W. et al. Relation between coronary artery stenosis and myocardial purine metabolism, histology and regional function in humans. J. Am. Coll. Cordial. 9, 1235-1242 (1987).
16. Vanoverschelde, J.L.J. et al. Chronic myocardial hibernation in humans. From bedside to bench. Circulation 95, 1961-1971 (1997).
17. Elsässer, A. & Schaper, J. Hibernating myocardium: adaptation or degeneration? Basic Res. Cardiol. 90, 47-48 (1995).
18. Kloner, R.A., Bolli, R., Marban, E., Reinlib, L. & Braunwald, E. Medical and cellular implications of stunning, hibernation and preconditioning. An NHLBI workshop. Circulation 97, 1848-1867 (1998).
19. Borgers, M. in Stunning, Hibernation, and Preconditioning: Clinical Pathophysiology of Myocardial Ischemia. (eds. Heyndrickx, G.R., Vatner, S.F. & Wijns, W.) 287-306 (Lippincott-Raven, Philadelphia, 1997).
20. Schwarz, E.R. et al. Myocyte degeneration and cell death in hibernating human myocardium. J. Am. Coll. Cardiol. 27, 1577-1585 (1996).
21. Shivalkar, B. et al. Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation 94, 308-315 (1996).
22. Chen, C. et al. Myocardial cell death and apoptosis in hibernating myocardium. J. Am. Coll. Cardiol. 30, 1407-1412 (1997).
23. nd 1999).
24. Hudlicka, O. & Brown, M.D. Postnatal growth of the heart and its blood vessels. J. Vasc. Res. 33, 266-287 (1996).
25. Tomanek, R.J. Formation of the coronary vasculature: a brief review. Cardiovasc. Res. 31, E46-51 (1996).
26. Hirschi, K.K., Rohovsky, S.A. & D'Amore, P.A. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate [published erratum in J. Cell Biol. 141, 1287 (1998)]. J. Cell. Biol. 141, 805-814 (1998).
27. Koblizek, T.I., Weiss, C., Yancopoulos, G.D., Deutsch, U. & Risau, W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8, 529-532 (1998).
28. Suri, C. et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180 (1996).
29. Evans, S.M. et al. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 (2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide). Br. J. Cancer 72, 875-882 (1995).
30. Carmeliet, P. et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation, and tumor angiogenesis. Nature 394, 485-490 (1998).
31. Zareba, W., Moss, A.J. & le Cessie, S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am. J. Cardiol. 74, 550-553 (1994).
32. Kaprielian, R.R. et al. Downregulation of immunodetectable connexin 43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation 97, 651-660 (1998).
33. Schaper, J. et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 83, 504-514 (1991).
34. Elsässer, A. et al. Hibernating myocardium. An incomplete adaptation to ischemia. Circulation 96, 2920-2931 (1997).
35. Ausma, J. et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96, 3157-3163 (1997).
36. Lopaschuk, G.D., Collins-Nakai, R.L. & Itoi, T. Developmental changes in energy substrate use by the heart. Cariovasc. Res. 26, 1172-1180 (1992).
37. Murda'h, M.A., McKenna, W.J. & Camm, A.J. Repolarization alternans: techniques, mechanisms, and cardiac vulnerability. Pacing Clin. Electrophysiol. 20, 2641-2657 (1997).
38. Shaw, D.B., Linker, N.J., Heaver, P.A. & Evans, R. Chronic sinoatrial disorder (sick sinus syndrome): a possible result of cardiac ischaemia. Br. Heart J. 58, 598-607 (1987).
39. Lopaschuk, G.D. & Stanley, W.C. Glucose metabolism in the ischemic heart. Circulation 85, 313-315 (1997).
40. Kremer, C., Breier, G., Risau, W. & Plate, K.H. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res. 57, 3852-3859 (1997).
41. Risau, W. Development and differentiation of endothelium. Kidney Int. Suppl. 67, 53-6 (1998).
42. Witzenbichler, B. et al. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am. J. Pathol. 153, 381-394 (1998).
43. Gerber, H.P., Condorelli, F., Park, J. & Ferrara, N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 272, 23659-23667 (1997).
44. Carmeliet, P. et al. Role of tissue factor in embryonic blood vessel development. Nature 383, 73-75 (1996).
45. Arber, S. et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393-403 (1997).